Kaldalón hf. (ICE:KALD)

Blueprint Medicines Ratios and Metrics

Market cap in millions ISK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	26,763	30,227	19,518	16,675	10,921	4,316
Market Cap Growth	54.87%	54.87%	17.05%	52.68%	153.02%	21.95%
Enterprise Value	67,796	60,502	43,590	31,256	11,317	5,535
Last Close Price	24.80	27.00	17.54	16.20	20.00	12.00
PE Ratio	8.83	9.36	6.18	8.48	9.49	11.65
PS Ratio	5.94	6.71	6.05	9.47	46.89	-
PB Ratio	1.03	1.17	0.84	0.81	1.31	0.93
P/TBV Ratio	1.03	1.17	0.84	0.83	1.34	0.93
P/FCF Ratio	12.59	14.22	23.29	43.20	-	-
P/OCF Ratio	12.59	14.22	23.29	43.20	-	-
EV/Sales Ratio	15.04	13.42	13.50	17.75	48.58	-
EV/EBIT Ratio	19.11	17.06	17.53	23.93	224.58	-
EV/FCF Ratio	31.90	28.47	52.02	80.97	-	-
Debt / Equity Ratio	1.65	1.65	1.31	0.98	1.21	0.30
Debt / FCF Ratio	20.12	20.12	36.25	52.50	-	-
Asset Turnover	0.07	0.07	0.06	0.05	0.02	-
Quick Ratio	0.44	0.44	0.28	1.03	0.58	0.19
Current Ratio	0.44	0.44	0.28	1.03	1.06	3.82
Return on Equity (ROE)	13.15%	13.15%	14.39%	14.42%	20.60%	8.38%
Return on Assets (ROA)	3.25%	3.25%	2.93%	2.43%	0.23%	-1.26%
Return on Capital (ROIC)	3.63%	3.63%	3.29%	2.74%	0.26%	-1.29%
Return on Capital Employed (ROCE)	5.00%	5.00%	4.90%	3.10%	0.30%	-
Earnings Yield	12.07%	10.69%	16.19%	11.80%	10.53%	8.58%
FCF Yield	7.94%	7.03%	4.29%	2.31%	-0.71%	-5.15%
Buyback Yield / Dilution	2.38%	2.38%	-45.01%	-86.40%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.